ATE526960T1 - Arzneimittel zur behandlung von grippe - Google Patents
Arzneimittel zur behandlung von grippeInfo
- Publication number
- ATE526960T1 ATE526960T1 AT08721158T AT08721158T ATE526960T1 AT E526960 T1 ATE526960 T1 AT E526960T1 AT 08721158 T AT08721158 T AT 08721158T AT 08721158 T AT08721158 T AT 08721158T AT E526960 T1 ATE526960 T1 AT E526960T1
- Authority
- AT
- Austria
- Prior art keywords
- products used
- medicinal products
- treat flu
- influenza
- prophylactic
- Prior art date
Links
- 229940126601 medicinal product Drugs 0.000 title 1
- 206010064097 avian influenza Diseases 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 230000000069 prophylactic effect Effects 0.000 abstract 2
- 230000001225 therapeutic effect Effects 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 125000004423 acyloxy group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000001589 carboacyl group Chemical group 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrane Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2007056872 | 2007-03-07 | ||
| PCT/JP2008/053738 WO2008108323A1 (ja) | 2007-03-07 | 2008-03-03 | インフルエンザ治療剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE526960T1 true ATE526960T1 (de) | 2011-10-15 |
Family
ID=39738201
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT08721158T ATE526960T1 (de) | 2007-03-07 | 2008-03-03 | Arzneimittel zur behandlung von grippe |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US20100204314A1 (de) |
| EP (1) | EP2123271B1 (de) |
| JP (2) | JP5286251B2 (de) |
| KR (1) | KR101473028B1 (de) |
| CN (1) | CN101715343B (de) |
| AT (1) | ATE526960T1 (de) |
| CA (1) | CA2680415A1 (de) |
| CY (1) | CY1112201T1 (de) |
| DK (1) | DK2123271T3 (de) |
| ES (1) | ES2372996T3 (de) |
| HR (1) | HRP20110861T1 (de) |
| PL (1) | PL2123271T3 (de) |
| PT (1) | PT2123271E (de) |
| SI (1) | SI2123271T1 (de) |
| TW (1) | TWI424841B (de) |
| WO (1) | WO2008108323A1 (de) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7960139B2 (en) | 2007-03-23 | 2011-06-14 | Academia Sinica | Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells |
| ES2442024T3 (es) | 2008-07-15 | 2014-02-07 | Academia Sinica | Matrices de glucano sobre portaobjetos de vidrio revestidos con aluminio de tipo PTFE y métodos relacionados |
| US11377485B2 (en) | 2009-12-02 | 2022-07-05 | Academia Sinica | Methods for modifying human antibodies by glycan engineering |
| US10087236B2 (en) | 2009-12-02 | 2018-10-02 | Academia Sinica | Methods for modifying human antibodies by glycan engineering |
| US10338069B2 (en) | 2010-04-12 | 2019-07-02 | Academia Sinica | Glycan arrays for high throughput screening of viruses |
| AU2011250970B2 (en) * | 2010-05-10 | 2016-12-15 | Sinica, Academia | Zanamivir phosphonate congeners with anti-influenza activity and determining oseltamivir susceptibility of influenza viruses |
| HK1199034A1 (en) * | 2011-12-16 | 2015-06-19 | Daiichi Sankyo Company, Limited | Method for producing neuraminic acid derivative |
| US10130714B2 (en) | 2012-04-14 | 2018-11-20 | Academia Sinica | Enhanced anti-influenza agents conjugated with anti-inflammatory activity |
| WO2014031498A1 (en) | 2012-08-18 | 2014-02-27 | Academia Sinica | Cell-permeable probes for identification and imaging of sialidases |
| EP3013365B1 (de) | 2013-06-26 | 2019-06-05 | Academia Sinica | Rm2-antigene und verwendung davon |
| EP3013347B1 (de) | 2013-06-27 | 2019-12-11 | Academia Sinica | Glykankonjugate und verwendung davon |
| JP6486368B2 (ja) | 2013-09-06 | 2019-03-20 | アカデミア シニカＡｃａｄｅｍｉａ Ｓｉｎｉｃａ | 改変されたグリコシル基を含む糖脂質を用いたヒトｉＮＫＴ細胞の活性化 |
| AU2015206370A1 (en) | 2014-01-16 | 2016-07-07 | Academia Sinica | Compositions and methods for treatment and detection of cancers |
| US10150818B2 (en) | 2014-01-16 | 2018-12-11 | Academia Sinica | Compositions and methods for treatment and detection of cancers |
| CN106415244B (zh) | 2014-03-27 | 2020-04-24 | 中央研究院 | 反应性标记化合物及其用途 |
| CA2950415A1 (en) | 2014-05-27 | 2015-12-03 | Academia Sinica | Anti-cd20 glycoantibodies and uses thereof |
| CN106661099A (zh) | 2014-05-27 | 2017-05-10 | 中央研究院 | 抗her2醣抗体及其用途 |
| US10118969B2 (en) | 2014-05-27 | 2018-11-06 | Academia Sinica | Compositions and methods relating to universal glycoforms for enhanced antibody efficacy |
| JP7093612B2 (ja) | 2014-05-27 | 2022-06-30 | アカデミア シニカ | Ｂａｃｔｅｒｏｉｄｅｓ由来のフコシダーゼおよびそれを使用する方法 |
| WO2015184001A1 (en) | 2014-05-28 | 2015-12-03 | Academia Sinica | Anti-tnf-alpha glycoantibodies and uses thereof |
| TWI745275B (zh) | 2014-09-08 | 2021-11-11 | 中央研究院 | 使用醣脂激活人類ｉＮＫＴ細胞 |
| US10495645B2 (en) | 2015-01-16 | 2019-12-03 | Academia Sinica | Cancer markers and methods of use thereof |
| US9975965B2 (en) | 2015-01-16 | 2018-05-22 | Academia Sinica | Compositions and methods for treatment and detection of cancers |
| JP6779887B2 (ja) | 2015-01-24 | 2020-11-04 | アカデミア シニカＡｃａｄｅｍｉａ Ｓｉｎｉｃａ | 新規なグリカンコンジュゲートおよびその使用方法 |
| EP3426693A4 (de) | 2016-03-08 | 2019-11-13 | Academia Sinica | Verfahren zur modularen synthese von n-glykanen und anordnungen davon |
| CA3034057A1 (en) | 2016-08-22 | 2018-03-01 | CHO Pharma Inc. | Antibodies, binding fragments, and methods of use |
| CN111787925A (zh) * | 2017-10-11 | 2020-10-16 | 生命科学股份有限公司 | N-乙酰神经氨酸组合物和使用方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6451766B1 (en) * | 1996-07-22 | 2002-09-17 | Sankyo Company, Limited | Neuraminic acid derivatives, their preparation and their medical use |
| US6340702B1 (en) * | 1996-07-22 | 2002-01-22 | Sankyo Company, Limited | Neuraminic acid derivatives, their preparation and their medical use |
| DE69709795T2 (de) * | 1996-07-22 | 2002-09-26 | Sankyo Co., Ltd. | Neuraminsäuredervate, ihre Herstellung und medizinische Verwendung |
| JP3209946B2 (ja) * | 1996-07-22 | 2001-09-17 | 三共株式会社 | ノイラミン酸誘導体 |
| JP4151800B2 (ja) | 1996-08-13 | 2008-09-17 | 第一三共株式会社 | ノイラミン酸化合物 |
| TWI291462B (en) * | 2000-04-25 | 2007-12-21 | Daiichi Sankyo Co Ltd | Hydrate crystal of neuraminic acid compound |
| JP3920041B2 (ja) * | 2000-04-25 | 2007-05-30 | 三共株式会社 | ノイラミン酸化合物の水和物及び結晶 |
| DE602006003600D1 (de) | 2005-08-22 | 2008-12-24 | Delphi Tech Inc | Nockenwellenversteller zur Einstellung der Phase zwischen einer Nockenwelle und einem Antriebsrad |
-
2008
- 2008-03-03 PL PL08721158T patent/PL2123271T3/pl unknown
- 2008-03-03 HR HR20110861T patent/HRP20110861T1/hr unknown
- 2008-03-03 KR KR1020097018422A patent/KR101473028B1/ko active Active
- 2008-03-03 JP JP2009502568A patent/JP5286251B2/ja active Active
- 2008-03-03 AT AT08721158T patent/ATE526960T1/de active
- 2008-03-03 CA CA002680415A patent/CA2680415A1/en not_active Abandoned
- 2008-03-03 EP EP08721158A patent/EP2123271B1/de not_active Not-in-force
- 2008-03-03 CN CN2008800149108A patent/CN101715343B/zh active Active
- 2008-03-03 ES ES08721158T patent/ES2372996T3/es active Active
- 2008-03-03 PT PT08721158T patent/PT2123271E/pt unknown
- 2008-03-03 WO PCT/JP2008/053738 patent/WO2008108323A1/ja not_active Ceased
- 2008-03-03 DK DK08721158.7T patent/DK2123271T3/da active
- 2008-03-03 US US12/449,909 patent/US20100204314A1/en not_active Abandoned
- 2008-03-03 SI SI200830440T patent/SI2123271T1/sl unknown
- 2008-03-07 TW TW097107984A patent/TWI424841B/zh active
-
2011
- 2011-12-30 CY CY20111101293T patent/CY1112201T1/el unknown
-
2013
- 2013-04-22 JP JP2013089202A patent/JP6012076B2/ja active Active
- 2013-08-27 US US14/010,784 patent/US20140018418A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20140018418A1 (en) | 2014-01-16 |
| TW200848018A (en) | 2008-12-16 |
| EP2123271A4 (de) | 2010-03-17 |
| WO2008108323A1 (ja) | 2008-09-12 |
| CN101715343A (zh) | 2010-05-26 |
| JP2013139483A (ja) | 2013-07-18 |
| DK2123271T3 (da) | 2012-01-23 |
| CA2680415A1 (en) | 2008-09-12 |
| CY1112201T1 (el) | 2015-12-09 |
| JP5286251B2 (ja) | 2013-09-11 |
| JPWO2008108323A1 (ja) | 2010-06-17 |
| PT2123271E (pt) | 2011-12-20 |
| PL2123271T3 (pl) | 2012-03-30 |
| TWI424841B (zh) | 2014-02-01 |
| KR101473028B1 (ko) | 2014-12-15 |
| US20100204314A1 (en) | 2010-08-12 |
| KR20090129414A (ko) | 2009-12-16 |
| EP2123271B1 (de) | 2011-10-05 |
| HK1137142A1 (en) | 2010-07-23 |
| JP6012076B2 (ja) | 2016-10-25 |
| EP2123271A1 (de) | 2009-11-25 |
| SI2123271T1 (sl) | 2012-05-31 |
| HRP20110861T1 (hr) | 2011-12-31 |
| ES2372996T3 (es) | 2012-01-30 |
| CN101715343B (zh) | 2012-09-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE526960T1 (de) | Arzneimittel zur behandlung von grippe | |
| MA37142A3 (fr) | Dérivés de dihydro-benzo-oxazine et de dihydro-pyrido-oxazine | |
| EA201001733A1 (ru) | Производные тиенопиридона в качестве активаторов амр-активированной протеинкиназы (амрк) | |
| NO20074592L (no) | Acetylenyl-pyrazolo-pyrimidinderivater som mGluR2-antagonister | |
| WO2008079339A3 (en) | Tetracycline derivatives for the treatment of bacterial, viral and parasitic infections | |
| MA38865A1 (fr) | Formulation comprenant un agent hypolipidémiant | |
| IL183373A0 (en) | 3-[2-(3-acylamino-2-oxo-2h-pyridin-1-yl)-acetylamino]-4-oxo-pentanoic acid derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof | |
| TW200616979A (en) | Non-nucleoside reverse transcriptase inhibitors | |
| CY1109569T1 (el) | Υποκατεστημενα παραγωγα κυκλοεξανο-1,4-διαμινης | |
| MY158069A (en) | Tricyclic compound and pharmaceutical use thereof | |
| EP1314719A4 (de) | Benzoesäurederivate und medikamente die diese als aktiven wirkstoff enthalten | |
| ATE441630T1 (de) | Substituierte cyclopenten-verbindungen | |
| WO2009051223A1 (ja) | 白内障処置のための医薬組成物 | |
| SA112330457B1 (ar) | مشتقات فينيل- ايزواوكسازول وعملية تحضيرها | |
| BRPI0512970A (pt) | prodrogas de inibidores da hiv protease | |
| SE0303480D0 (sv) | Benzofuranes | |
| NO20064344L (no) | Caspaseinhibitorer og anvendelser derav | |
| DE602004019778D1 (de) | Verwendung von 2-amino-1,3-propandiolderivaten zur herstellung eines medikaments zur behandlung von bestimmten schmerzen | |
| NO20063859L (no) | Cykloalkylsubstituerte 7-amino-4-kinolon-3-karboksylsyrederivater, fremgangsmate for fremstilling derav og anvendelse derav som medikamenter | |
| EA201190003A1 (ru) | Производные хроменона в качестве trpv3 антагонистов | |
| BR112014005034A2 (pt) | compostos e composições de fragrância | |
| NO20060277L (no) | Anvendelse av bisyklo [2.2.1] heptanderivater til fremstilling av nevrobeskyttende farmasoytiske sammensetninger | |
| AU2003216965A1 (en) | Compounds, particularly of urea derivatives or ester derivatives of haloacetamidobenzoic acid and use thereof for the treatment of parasitic diseases | |
| BR0312615A (pt) | Compostos úteis como inibidores de metaloproteinases | |
| BR0312698A (pt) | Cefalosporinas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 2123271 Country of ref document: EP |